Literature DB >> 32156703

Structure of an ancestral mammalian family 1B1 cytochrome P450 with increased thermostability.

Aaron G Bart1, Kurt L Harris2, Elizabeth M J Gillam2, Emily E Scott3.   

Abstract

Mammalian cytochrome P450 enzymes often metabolize many pharmaceuticals and other xenobiotics, a feature that is valuable in a biotechnology setting. However, extant P450 enzymes are typically relatively unstable, with T 50 values of ∼30-40 °C. Reconstructed ancestral cytochrome P450 enzymes tend to have variable substrate selectivity compared with related extant forms, but they also have higher thermostability and therefore may be excellent tools for commercial biosynthesis of important intermediates, final drug molecules, or drug metabolites. The mammalian ancestor of the cytochrome P450 1B subfamily was herein characterized structurally and functionally, revealing differences from the extant human CYP1B1 in ligand binding, metabolism, and potential molecular contributors to its thermostability. Whereas extant human CYP1B1 has one molecule of α-naphthoflavone in a closed active site, we observed that subtle amino acid substitutions outside the active site in the ancestor CYP1B enzyme yielded an open active site with four ligand copies. A structure of the ancestor with 17β-estradiol revealed only one molecule in the active site, which still had the same open conformation. Detailed comparisons between the extant and ancestor forms revealed increases in electrostatic and aromatic interactions between distinct secondary structure elements in the ancestral forms that may contribute to their thermostability. To the best of our knowledge, this represents the first structural evaluation of a reconstructed ancestral cytochrome P450, revealing key features that appear to contribute to its thermostability.
© 2020 Bart et al.

Entities:  

Keywords:  16beta-estradiol; CYP1B1; X-ray crystallography; alpha-naphthoflavone; ancestral reconstruction; cytochrome P450; drug metabolism; enzyme stability; enzyme structure; estradiol; human; membrane protein; protein engineering; protein structure; reconstructed ancestral protein; synthetic biology; thermostability

Mesh:

Substances:

Year:  2020        PMID: 32156703      PMCID: PMC7186169          DOI: 10.1074/jbc.RA119.010727

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Crystal structure of a thermophilic cytochrome P450 from the archaeon Sulfolobus solfataricus.

Authors:  J K Yano; L S Koo; D J Schuller; H Li; P R Ortiz de Montellano; T L Poulos
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

2.  Detection, delineation, measurement and display of cavities in macromolecular structures.

Authors:  G J Kleywegt; T A Jones
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-03-01

3.  Metabolism of melatonin by human cytochromes p450.

Authors:  Xiaochao Ma; Jeffrey R Idle; Kristopher W Krausz; Frank J Gonzalez
Journal:  Drug Metab Dispos       Date:  2004-12-22       Impact factor: 3.922

4.  Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties.

Authors:  Rudi Fasan; Mike M Chen; Nathan C Crook; Frances H Arnold
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

5.  Quantitative whole-cell cytochrome P450 measurement suitable for high-throughput application.

Authors:  Wayne A Johnston; Weiliang Huang; James J De Voss; Martin A Hayes; Elizabeth M J Gillam
Journal:  J Biomol Screen       Date:  2008-01-23

Review 6.  Cytochrome P450: taming a wild type enzyme.

Authors:  Sang Taek Jung; Ryan Lauchli; Frances H Arnold
Journal:  Curr Opin Biotechnol       Date:  2011-03-14       Impact factor: 9.740

Review 7.  Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1.

Authors:  G I Murray; W T Melvin; W F Greenlee; M D Burke
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

8.  Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.

Authors:  T Shimada; E M Gillam; T R Sutter; P T Strickland; F P Guengerich; H Yamazaki
Journal:  Drug Metab Dispos       Date:  1997-05       Impact factor: 3.922

9.  Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.

Authors:  T Shimada; H Yamazaki; M Foroozesh; N E Hopkins; W L Alworth; F P Guengerich
Journal:  Chem Res Toxicol       Date:  1998-09       Impact factor: 3.739

10.  Structure and direct electrochemistry of cytochrome P450 from the thermoacidophilic crenarchaeon, Sulfolobus tokodaii strain 7.

Authors:  Yusuke Oku; Akashi Ohtaki; Shigehiro Kamitori; Nobuhumi Nakamura; Masafumi Yohda; Hiroyuki Ohno; Yutaka Kawarabayasi
Journal:  J Inorg Biochem       Date:  2004-07       Impact factor: 4.155

View more
  3 in total

1.  FireProtASR: A Web Server for Fully Automated Ancestral Sequence Reconstruction.

Authors:  Milos Musil; Rayyan Tariq Khan; Andy Beier; Jan Stourac; Hannes Konegger; Jiri Damborsky; David Bednar
Journal:  Brief Bioinform       Date:  2021-07-20       Impact factor: 11.622

2.  Bi-alignments with affine gaps costs.

Authors:  Peter F Stadler; Sebastian Will
Journal:  Algorithms Mol Biol       Date:  2022-05-16       Impact factor: 1.721

3.  Engineering of Ancestors as a Tool to Elucidate Structure, Mechanism, and Specificity of Extant Terpene Cyclase.

Authors:  Karen Schriever; Patricia Saenz-Mendez; Reshma Srilakshmi Rudraraju; Natalie M Hendrikse; Elton P Hudson; Antonino Biundo; Robert Schnell; Per-Olof Syrén
Journal:  J Am Chem Soc       Date:  2021-01-26       Impact factor: 15.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.